Abstract ND06: ABBV-CLS-484: An active site PTPN2/N1 inhibitor that augments the immune response and sensitizes tumors to immune-mediated killing
Baumgartner, Christina K., Paddock, Marcia N., Frost, Jennifer M., Hamel, Keith M., McGuire, Kathleen A., Halliwill, Kyle, Xiong, Zhaoming, Mu, Liang, Klinge, Kelly, Geda, Prasanthi, Aguado, Jaqueline, Bulic, Marinka, Farney, Elliot P., Yates, Kathleen B., Manguso, Robert T., Beauregard, Clay, Kym, Philip R.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article